373 related articles for article (PubMed ID: 16099553)
21. Co-expression of HLA-B7 and HLA-B27 alleles is associated with B7-restricted immunodominant responses following influenza infection.
Akram A; Inman RD
Eur J Immunol; 2013 Dec; 43(12):3254-67. PubMed ID: 24113999
[TBL] [Abstract][Full Text] [Related]
22. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
[TBL] [Abstract][Full Text] [Related]
23. Precursor frequency and competition dictate the HLA-A2-restricted CD8+ T cell responses to influenza A infection and vaccination in HLA-A2.1 transgenic mice.
Tan AC; La Gruta NL; Zeng W; Jackson DC
J Immunol; 2011 Aug; 187(4):1895-902. PubMed ID: 21765016
[TBL] [Abstract][Full Text] [Related]
24. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
[TBL] [Abstract][Full Text] [Related]
25. Response of established human breast tumors to vaccination with mammaglobin-A cDNA.
Narayanan K; Jaramillo A; Benshoff ND; Campbell LG; Fleming TP; Dietz JR; Mohanakumar T
J Natl Cancer Inst; 2004 Sep; 96(18):1388-96. PubMed ID: 15367572
[TBL] [Abstract][Full Text] [Related]
26. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients.
Jaramillo A; Narayanan K; Campbell LG; Benshoff ND; Lybarger L; Hansen TH; Fleming TP; Dietz JR; Mohanakumar T
Breast Cancer Res Treat; 2004 Nov; 88(1):29-41. PubMed ID: 15538043
[TBL] [Abstract][Full Text] [Related]
27. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
[TBL] [Abstract][Full Text] [Related]
28. A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.
Conforti A; Peruzzi D; Giannetti P; Biondo A; Ciliberto G; La Monica N; Aurisicchio L
J Immunother; 2009 Sep; 32(7):744-54. PubMed ID: 19561534
[TBL] [Abstract][Full Text] [Related]
29. Chlamydia pneumoniae genome sequence analysis and identification of HLA-A2-restricted CD8+ T cell epitopes recognized by infection-primed T cells.
Capo S; Nuti S; Scarselli M; Tavarini S; Montigiani S; Mori E; Finco O; Abrignani S; Grandi G; Bensi G
Vaccine; 2005 Oct; 23(42):5028-37. PubMed ID: 15982792
[TBL] [Abstract][Full Text] [Related]
30. Human memory CTL response specific for influenza A virus is broad and multispecific.
Gianfrani C; Oseroff C; Sidney J; Chesnut RW; Sette A
Hum Immunol; 2000 May; 61(5):438-52. PubMed ID: 10773346
[TBL] [Abstract][Full Text] [Related]
31. Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes.
Sundar K; Boesen A; Coico R
Virology; 2007 Apr; 360(2):257-63. PubMed ID: 17123567
[TBL] [Abstract][Full Text] [Related]
32. Relation between viral fitness and immune escape within the hepatitis C virus protease.
Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
[TBL] [Abstract][Full Text] [Related]
33. The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificity.
Bernhard EJ; Le AX; Yannelli JR; Holterman MJ; Hogan KT; Parham P; Engelhard VH
J Immunol; 1987 Dec; 139(11):3614-21. PubMed ID: 2445816
[TBL] [Abstract][Full Text] [Related]
34. Identification of naturally processed human ovarian peptides recognized by tumor-associated CD8+ cytotoxic T lymphocytes.
Fisk B; Anderson BW; Gravitt KR; O'Brian CA; Kudelka AP; Murray JL; Wharton JT; Ioannides CG
Cancer Res; 1997 Jan; 57(1):87-93. PubMed ID: 8988046
[TBL] [Abstract][Full Text] [Related]
35. Transgenic mice expressing human HLA and CD8 molecules generate HLA-restricted measles virus cytotoxic T lymphocytes of the same specificity as humans with natural measles virus infection.
Tishon A; LaFace DM; Lewicki H; van Binnendijk RS; Osterhaus A; Oldstone MB
Virology; 2000 Sep; 275(2):286-93. PubMed ID: 10998329
[TBL] [Abstract][Full Text] [Related]
36. Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope.
Brinster C; Muguet S; Lone YC; Boucreux D; Renard N; Fournillier A; Lemonnier F; Inchauspé G
Hepatology; 2001 Dec; 34(6):1206-17. PubMed ID: 11732011
[TBL] [Abstract][Full Text] [Related]
37. Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses.
Didierlaurent A; Ramirez JC; Gherardi M; Zimmerli SC; Graf M; Orbea HA; Pantaleo G; Wagner R; Esteban M; Kraehenbuhl JP; Sirard JC
Vaccine; 2004 Sep; 22(25-26):3395-403. PubMed ID: 15308364
[TBL] [Abstract][Full Text] [Related]
38. HLA-restricted recognition of viral antigens in HLA transgenic mice.
Kievits F; Ivanyi P; Krimpenfort P; Berns A; Ploegh HL
Nature; 1987 Oct 1-7; 329(6138):447-9. PubMed ID: 2821399
[TBL] [Abstract][Full Text] [Related]
39. Identification of interleukin-13 receptor alpha2 peptide analogues capable of inducing improved antiglioma CTL responses.
Eguchi J; Hatano M; Nishimura F; Zhu X; Dusak JE; Sato H; Pollack IF; Storkus WJ; Okada H
Cancer Res; 2006 Jun; 66(11):5883-91. PubMed ID: 16740728
[TBL] [Abstract][Full Text] [Related]
40. Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.
Hoffmann TK; Donnenberg AD; Finkelstein SD; Donnenberg VS; Friebe-Hoffmann U; Myers EN; Appella E; DeLeo AB; Whiteside TL
Cancer Res; 2002 Jun; 62(12):3521-9. PubMed ID: 12067999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
